[2015-Feb-13] FDA approves Lenvima for a type of thyroid cancer

[2015-Feb-13] FDA approves Lenvima for a type of thyroid cancer

http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm434288.htm

Lenvima.cdx

Junji Matsui, Yasuhiro Funahashi, Toshimitsu Uenaka, Tatsuo Watanabe, Akihiko Tsuruoka and Makoto Asada, Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase, Clin. Cancer Res., 2008, 14 (17), pp 5459-5465

http://dx.doi.org/10.1158/1078-0432.CCR-07-5270

Haizhen Zhong and J. Phillip Bowen, Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways, Curr. Top. Med. Chem., 2011, 11 (12), pp 1571-1590

http://dx.doi.org/10.2174/156802611795860924